BioSpace News Archive

Genetown

Wave Life Sciences to Develop Programs in Rare, Genetic Eye Diseases

Research will focus on inherited retinal diseases associated with RHO, USH2A, ABCA4 and CEP290

October 11, 2018
·
5 min read
Genetown

TESARO Announces Data Presentations at the ESMO 2018 Congress

TESARO, Inc. today announced that data from six abstracts will be presented at the European Society for Medical Oncology (ESMO) Congress from October 19-23, 2018 in Munich, Germany.

October 11, 2018
·
5 min read
Policy

Trump Signs FTC Law That Allows for Biosimilar Scrutiny

President Donald Trump signed a bill into law yesterday that requires pharmaceutical companies to provide details of biosimilar deals to the Federal Trade Commission (FTC) for antitrust scrutiny.

October 11, 2018
·
3 min read
·
Mark Terry
Deals

CVS and Aetna Cleared for Merger as Companies Tighten Leadership Roles

The U.S. Department of Justice has given preliminary approval for CVS’ $69 billion acquisition of Aetna after Aetna divested its Medicare Part D business.

October 11, 2018
·
3 min read
·
Alex Keown
Drug Development

October 12 Research Roundup: Alzheimer’s, CRISPR, Breast Cancer and Global Warming

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

October 11, 2018
·
7 min read
·
Mark Terry
How to Reach Your Goals at Work Despite Negative Nancy

“That can never be done.” “We’ve tried that already.” “Those plans always fail around here.” “We’re smart, and have already thought of everything.” Those are just a few of the statements you might hear from a “Negative Nancy” at work

October 11, 2018
·
3 min read
·
Porschia Parker
Business

A Look Inside New MS Data With Biogen’s Medical Director of Clinical Development

There is a lot of anticipated excitement for multiple sclerosis treatments unveiled by Biogen at the 34th Congress of the European Committee for Treatment and Research in MS in Berlin.

October 11, 2018
·
3 min read
·
Alex Keown
Job Trends

Lipocine Announces LPCN 1144 Clinical Trial Results Selected for Late-Breaker Presentation at The Liver Meeting® 2018

Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company, announced today that it has been selected to present LPCN 1144 results as part of the late-breaker session of The Liver Meeting® 2018.

October 11, 2018
·
4 min read
Business

The Michael J. Fox Foundation Partners with Cohen Veterans Bioscience on BRAIN Commons, Harnessing the Power of Big Data for Brain Diseases

Today, at the Cohen Veterans Care Summit, the Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Cohen Veterans Bioscience announce their partnership on BRAIN Commons,

October 11, 2018
·
3 min read
Biotech Beach

Bridgepoint Education Golf Invitational Will Raise Funds for Rady Children’s Hospital

Bridgepoint Education, Inc. (NYSE: BPI) announced that the 11th Annual Bridgepoint Education Golf Invitational will be held on Monday, October 15, at the Fairbanks Ranch Country Club in Rancho Santa Fe, Calif.

October 11, 2018
·
1 min read